Readystate Asset Management LP Purchases 7,288 Shares of Envista Holdings Co. (NYSE:NVST)

Readystate Asset Management LP grew its position in shares of Envista Holdings Co. (NYSE:NVST) by 16.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 51,016 shares of the company’s stock after acquiring an additional 7,288 shares during the period. Readystate Asset Management LP’s holdings in Envista were worth $1,008,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Ariel Investments LLC lifted its stake in shares of Envista by 11.0% in the 2nd quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock valued at $164,157,000 after acquiring an additional 978,952 shares during the last quarter. Nuance Investments LLC lifted its stake in shares of Envista by 4.4% in the 3rd quarter. Nuance Investments LLC now owns 7,346,534 shares of the company’s stock valued at $145,168,000 after acquiring an additional 308,221 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Envista by 15.4% in the 2nd quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock valued at $111,864,000 after acquiring an additional 897,141 shares during the last quarter. Clarkston Capital Partners LLC lifted its stake in shares of Envista by 0.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 4,347,300 shares of the company’s stock valued at $85,903,000 after acquiring an additional 17,085 shares during the last quarter. Finally, Jupiter Asset Management Ltd. bought a new stake in shares of Envista in the 2nd quarter valued at about $69,534,000.

Envista Price Performance

NVST stock opened at $20.57 on Thursday. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $25.64. The firm has a 50-day moving average of $19.96 and a 200 day moving average of $18.34. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The company had revenue of $601.00 million during the quarter, compared to the consensus estimate of $590.34 million. During the same period in the prior year, the firm earned $0.43 earnings per share. Envista’s revenue was down 4.8% on a year-over-year basis. As a group, equities research analysts anticipate that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

Analysts Set New Price Targets

NVST has been the subject of a number of recent research reports. Stifel Nicolaus boosted their target price on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Mizuho assumed coverage on Envista in a research note on Wednesday. They issued an “underperform” rating and a $20.00 target price for the company. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and raised their target price for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Wells Fargo & Company assumed coverage on Envista in a research note on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 target price on the stock. Finally, Evercore ISI raised their target price on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $20.65.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.